Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To evaluate the clinical effect of a 100 mg/day enteric coated aspirin vs placebo in the reduction of CVD events in patients at moderate risk of CHD events (approx 10 - 20% 10 year-risk). This corresponds to a patient population mean 10-year CVD risk of approx 30% based on the underlying assumption at study start.
Inclusion criteria
- Patients at moderate risk of CHD events (10-20% 10-year CHD risk;
- approximately 30% 10-year risk of CVD events based on the underlying
- assumption at study start)